Pharmacy Services
Hylenex Injection from Baxter Healthcare - Recall
May 27, 2010
Baxter Healthcare is recalling all lots of Hylenex (recombinant hyaluronidase) injection due to glass particulates found in a few vials during routine testing. No adverse events have been reported at this time. Hylenex is a tissue permeability modifier labeled as an adjuvant in subcutaneous fluid hydration and to increase the absorption and dispersion of injected medications. Baxter will contact customers about product returns and will continue to monitor and investigate any issues that come up regarding this recall. Report adverse events related to this recall to the MedWatch Program.
Additional information is available at the following links:
- MedWatch Alert – May 26, 2010
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm213532.htm - Company Press Release – May 17, 2010
http://www.baxter.com/press_room/press_releases/2010/05_17_10_hylenex.html
Updated
May 27, 2010; May 18, 2010; University of Utah, Drug Information Service. Copyright 2010, Drug Information Service, University of Utah, Salt Lake City, UT.
Social Media
Copyright © 2013 University of Utah Health Care